IL33 and asthma: Thus, in mild asthma, the protection offered by epithelial-derived Type I IFNs towards MCs may outweigh the negative effect of IL-33 on ICAM1 expression and viral entry whereas in severe disease, a lack of epithelial IFNs may render the MCs more vulnerable to infection.